Medibio Ltd
ASX:MEB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Medibio Ltd
Gross Profit
Medibio Ltd
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medibio Ltd
ASX:MEB
|
Gross Profit
AU$963.6k
|
CAGR 3-Years
10%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
4DMedical Ltd
ASX:4DX
|
Gross Profit
AU$5.3m
|
CAGR 3-Years
103%
|
CAGR 5-Years
140%
|
CAGR 10-Years
N/A
|
|
|
CogState Ltd
ASX:CGS
|
Gross Profit
$31.7m
|
CAGR 3-Years
14%
|
CAGR 5-Years
19%
|
CAGR 10-Years
12%
|
|
|
Pro Medicus Ltd
ASX:PME
|
Gross Profit
AU$248.4m
|
CAGR 3-Years
33%
|
CAGR 5-Years
33%
|
CAGR 10-Years
27%
|
|
|
Alcidion Group Ltd
ASX:ALC
|
Gross Profit
AU$41.6m
|
CAGR 3-Years
6%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
A
|
Artrya Ltd
ASX:AYA
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Medibio Ltd
Glance View
Medibio Ltd. engages in the clinical research, product development and early stage commercialization of a mental health technology. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2001-01-29. The firm offers mental well-being solutions for businesses and are also developing products to serve the healthcare provider market. The company offers a software called MEBsleep, a medical device that analyses Electroencephalogram (EEG) and Electrocardiogram (ECG) data collected during polysomnography to verify sleep stages and heart rate variability (HRV) in patients suffering from primary or secondary sleep disturbances. The Company’s subsidiaries include Bioprospect Australia Pty Ltd, Australian Phytochemicals Pty Ltd, BioProspect America Pty Ltd, Medibio Limited USA, Invatec Health Pty Ltd and Annapanna Pty Ltd.
See Also
What is Medibio Ltd's Gross Profit?
Gross Profit
963.6k
AUD
Based on the financial report for Jun 30, 2023, Medibio Ltd's Gross Profit amounts to 963.6k AUD.
What is Medibio Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
-18%
Over the last year, the Gross Profit growth was -4%. The average annual Gross Profit growth rates for Medibio Ltd have been 10% over the past three years , -18% over the past five years .
